Amanda Saylor, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1441 W Rue Paris Pl, Inverness, IL 60067 Phone: 727-946-6534 |
Elena Rose Sorrentino Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 Plymouth Dr, Inverness, IL 60067 Phone: 847-494-2714 |
Elena Disanto Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1642 W Colonial Pkwy, Inverness, IL 60067 Phone: 847-533-6224 |
News Archive
"The need to ensure that people in Africa have access to essential, high quality, safe and affordable medicines has just received a major boost with the launch of the East African Community (EAC) Medicines Registration Harmonization Project in Arusha, Tanzania, on 30 March 2011," UNAIDS reports in a feature story on its website.
The University of Louisville has received a $3.15 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to support the UofL James Graham Brown Cancer Center and cancer research taking place in Owensboro. The grant will be matched with state "Bucks for Brains" funding to bring more than $4.5 million to the Owensboro Cancer Research Program.
To date, studies in pregnant women examining transport of drugs across the placenta are rare and inadequate, said Tomo Nabekura, PhD. Such knowledge could be vital to preserving fetal health. In a new laboratory study, Nabekura and colleagues have illuminated a piece of this puzzle, and the results hint that mothers taking new anti-hepatitis C and/or anti-HIV drugs along with anti-hypertensives or non-steroidal anti-inflammatories (NSAIDs) could be raising the risk of birth defects or stunting fetal growth, respectively.
Biological Psychiatry has published a new study revising the outdated estimates of the prevalence of eating disorders in the United States.
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at The University of Texas M. D. Anderson Cancer Center.
› Verified 6 days ago